Roswell Park Comprehensive Cancer Institute
Supporter
Membership discount for your BMC & SpringerOpen article processing charges (APCs)
As an affiliated author, a membership discount is available on your APC.
Please follow the submission guidelines to benefit from this membership discount.
Roswell Park Comprehensive Cancer Institute's Articles
Page 4 of 17
-
Citation: Journal for ImmunoTherapy of Cancer 2019 7:189
-
Systematic evaluation of RNA-Seq preparation protocol performance
Citation: BMC Genomics 2019 20:571 -
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
Citation: Journal for ImmunoTherapy of Cancer 2019 7:156 -
Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma
Citation: Journal for ImmunoTherapy of Cancer 2019 7:155 -
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
Citation: BMC Cancer 2019 19:504 -
OSCI: standardized stem cell ontology representation and use cases for stem cell investigation
Citation: BMC Bioinformatics 2019 20(Suppl 5):180 -
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Citation: Journal for ImmunoTherapy of Cancer 2019 7:73 -
Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study
Citation: Clinical Epigenetics 2019 11:45 -
Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells
Citation: Genome Biology 2019 20:37 -
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
Citation: Journal for ImmunoTherapy of Cancer 2019 7:27 -
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Citation: Journal for ImmunoTherapy of Cancer 2019 7:18 -
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing
Citation: BMC Medical Informatics and Decision Making 2019 19:14 -
A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells
Citation: Journal for ImmunoTherapy of Cancer 2019 7:7 -
Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders
Citation: Journal for ImmunoTherapy of Cancer 2018 6:159 -
Effects of a novel peptide Ac-SDKP in radiation-induced coronary endothelial damage and resting myocardial blood flow
Citation: Cardio-Oncology 2018 4:8 -
A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer
Citation: BMC Cancer 2018 18:1183 -
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
Citation: Breast Cancer Research 2018 20:146 -
Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
Citation: Radiation Oncology 2018 13:214 -
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth
Citation: Breast Cancer Research 2018 20:131 -
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Citation: Journal for ImmunoTherapy of Cancer 2018 6:109